Guggenheim Investments Named U.S. Fixed-Income Manager of the Year Celebrating Excellence in Asset Management By [Your Name], Posted on October 12, 2022 Exciting news in the world of finance as Guggenheim Investments, the global asset management and investment advisory business of Guggenheim Partners, has been honored with the prestigious title of U.S. Fixed-Income Manager of…

Kolaboration Ventures Takes Growth to New Heights with Mission Nurseries Acquisition: Expanding Product Lineup Description: Transformational deal will combine best-in-class wholesale, retail, manufacturing and cultivation operations with an expanded product line-up that customers love in the largest cannabis market in the U.S. Kolaboration Ventures Corporation Kolaboration Ventures Corporation RIO VISTA, Calif., Oct. 10, 2022 (GLOBE…

Duck Creek and SBS Partner Up for Enhanced Claims Replacement Solutions Collaboration for Innovation SBS, a prominent provider of claims replacement solutions, has recently joined forces with Duck Creek Technologies, a leading intelligent solutions provider for property and casualty insurance. This collaboration marks a significant step towards enhancing tech-enabled content validation and replacement in the…

Bank of England Launches Temporary Expanded Collateral Repo Facility Overview The Bank of England recently announced the launch of a temporary expanded collateral repo facility in response to changing market conditions and increasing demand for liquidity. This facility will provide additional support to financial institutions by allowing them to use a wider range of collateral…

Fulgent Genetics, Inc.: A Closer Look at the Securities Class Action Lawsuit The Legal Battle Unfolds On October 9, 2022, the law firm of Kessler Topaz Meltzer & Check, LLP announced the filing of a securities class action lawsuit against Fulgent Genetics, Inc. The lawsuit, filed in the United States District Court for the Central…

Revolutionizing Oncology: Radiomedix Secures $40 Million in Series A Financing for Groundbreaking Targeted Alpha Therapy and Diagnostic Radiopharmaceuticals HOUSTON and BURLINGTON, Ontario, Oct. 07, 2022 (GLOBE NEWSWIRE) — RadioMedix, Inc. (“RadioMedix” or “Company”), a clinical-stage biotechnology company announced an agreement with an entity related to Portland Investment Counsel Inc. (“Portland”) involving an equity investment of…

Capital Southwest Announces Preliminary Estimate of Second Quarter 2023 Operating Results Overview DALLAS, Oct. 07, 2022 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest,” the “Company” or “we”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, is pleased to…

Join Us at the 2022 PDA Pharmaceutical Microbiology Conference: Discover the Latest Innovations from Rapid Micro Biosystems! Get ready for an experience like no other! Exciting news for all those in the pharmaceutical industry! Are you passionate about staying ahead of the curve in the world of pharmaceutical microbiology? Do you want to be at…